关于Elekta.

关于Elekta.

通过精密放射医学，Elekta正在帮助临床医生关注它的重要性，使他们能够保护其患者重要的时刻。

Our legacy of innovation drives us forward

For almost five decades, Elekta has been a leader in precision radiation medicine. Our more than 4,000 employees worldwide are committed to ensuring everyone with cancer in the world has access to – and benefits from – more precise, personalized radiotherapy treatments. Our solutions for cancer care and brain disorders are tailored to target the tumor and protect the patient.

Prof Lars Leksell
“教授Lars Leksell（1907 - 1987年）是针对先进放射胶带平台的放射外科和开发人员的发明者，它是他的名字，Leksell GammaKnife®。Elekta由Lars Leksell成立近50年前。“

Pioneer in Precision Radiation Medicine

Pioneer in Precision Radiation Medicine
2400万

Access for all

对于ELEKTA，精密放射药意味着提供全球可访问，精确和个性化的放射治疗，该靶向肿瘤并保护患者。利用信息引导护理的智能，我们的放射疗法可以快速响应并适应改变肿瘤形状，位置和生物学，所有内容都在流线型处理计划中。

Boy and teacher

Everyone deserves high-quality care

Innovative solutions

Elekta is pushing the boundaries of radiation therapy to improve access for advanced, high quality cancer care that offers high-end precision, is cost-effective, and efficient with precise, personalized treatments.

High-end care
High-end care
High-end care
High-end care
High-end care
High-end care

Find out more about our总部和全球地点,the management team,career opportunities和investor relationson elekta.com. Click这里to contact us directly.

1. Cancer Research UK – cancer statistics. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/worldwide-cancer#heading-Zero
Last accessed: September 2018.
2. WHO cancer factsheet. Available from: http://www.who.int/en/news-room/fact-sheets/detail/cancer Last accessed: September 2018.
3. Cancer Research - Advancing Care, Advancing Years. Available from: https://www.cancerresearchuk.org/sites/default/files/advancing_care_advancing_years
Last accessed: September 2018.
4. Lievens Y等人。放射线和2017年oncol; 125：175-177。
5. Atun R, et al. Lancet Oncol Commission 2015; 16(10): 1153-1186. Date of preparation: September 2018.